THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 95 filers reported holding THERAVANCE INC in Q4 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $178,000 | +42.4% | 16,837 | -7.0% | 0.00% | – |
| Q3 2015 | $125,000 | -61.9% | 18,095 | 0.0% | 0.00% | – |
| Q2 2015 | $328,000 | +24.7% | 18,095 | +12.2% | 0.00% | – |
| Q1 2015 | $263,000 | +40.6% | 16,130 | +26.9% | 0.00% | – |
| Q4 2014 | $187,000 | -15.4% | 12,711 | 0.0% | 0.00% | – |
| Q3 2014 | $221,000 | – | 12,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 20,705,801 | $640,637,000 | 15.48% |
| Litespeed Management, L.L.C. | 1,931,554 | $59,762,000 | 6.48% |
| Realm Partners LLC | 323,121 | $9,997,000 | 5.75% |
| Foundation Asset Management, LP | 612,327 | $18,945,000 | 5.15% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,937 | $86,816,000 | 3.37% |
| Proxima Capital Management, LLC | 513,500 | $15,888,000 | 2.99% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 6,955,078 | $215,190,000 | 2.46% |
| SECTORAL ASSET MANAGEMENT INC | 1,851,088 | $57,273,000 | 2.36% |
| BB BIOTECH AG | 888,244 | $27,482,000 | 1.42% |
| Yakira Capital Management, Inc. | 43,000 | $1,330,000 | 1.19% |